Activation of Wnt/β‑Catenin‑p130/E2F4 promotes the differentiation of bone marrow‑derived mesenchymal stem cells into type II alveolar epithelial cells through cell cycle arrest

The results of our previous study demonstrated that activation of the Wnt/β-catenin pathway increased the differentiation of mesenchymal stem cells (MSCs) into type II alveolar epithelial (AT II) cells; however, the specific mechanisms remain unclear. The present study aimed to evaluate the role of Wnt/β-catenin-p130/E2F transcription factor 4 (E2F4) in regulating the differentiation of mouse MSCs (mMSCs) into AT II cells, and to determine the specific mechanisms. mMSCs with p130 or E2F4 overexpression were constructed using lentiviral vectors. Differentiation of mMSCs into AT II cells was promoted using a modified coculture system with murine lung epithelial-12 cells incubated in small airway growth medium for 7-14 days. The differentiation efficiency was detected using immunofluorescence, western blot analysis and transmission electron microscopy. To detect the association between the canonical Wnt pathway and p130/E2F4, 4 mmol/l lithium chloride (LiCl) or 200 ng/ml Dickkopf-related protein 1 (DKK-1) was also added to the coculture system. Following differentiation, the cell cycle of mMSCs was evaluated using flow cytometry. The results of the present study demonstrated that surfactant protein C (SP-C) protein expression was higher in the p130 overexpression (MSC-p130) and E2F4 overexpression (MSC-E2F4) groups compared with the normal control mMSCs group following differentiation into AT II cells. Similar results for SP-C protein expression and lamellar body-like structures were also observed using immunofluorescence analysis and electron microscopy. Following the addition of LiCl into the coculture system for activation of the Wnt/β-catenin signaling pathway, phosphorylated (p)-p130/p130 was slightly decreased at 7 days and E2F4 was increased both at 7 and 14 days in mMSCs. Furthermore, the p-p130/p130 ratio was significantly increased at 14 days and E2F4 was decreased both at 7 and 14 days following DKK-1-mediated inhibition of the Wnt pathway. The results of the present study demonstrated that the numbers of cells in G1 and S phases were increased following activation of the Wnt pathway and decreased following Wnt pathway inhibition. However, the number of cells in G1 phase was increased following the differentiation of mMSCs overexpressing p130 or E2F4. Therefore, the results of the present study revealed that the canonical Wnt signaling pathway may affect the differentiation of MSCs into AT II cells via regulation of downstream p130/E2F4. The specific mechanisms may be associated with G1 phase extension in the cell cycle of MSCs.

[1]  M. Rehan,et al.  Mesenchymal stromal cell aging impairs the self-organizing capacity of lung alveolar epithelial stem cells , 2021, bioRxiv.

[2]  L. Braga,et al.  The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung , 2021, International journal of molecular sciences.

[3]  R. Mason Thoughts on the alveolar phase of COVID-19 , 2020, American journal of physiology. Lung cellular and molecular physiology.

[4]  M. Zeng,et al.  Overexpression of FoxM1 promotes differentiation of bone marrow mesenchymal stem cells into alveolar type II cells through activating Wnt/β-catenin signalling. , 2020, Biochemical and biophysical research communications.

[5]  P. Pessina,et al.  Mesenchymal Stem Cells Increase Alveolar Differentiation in Lung Progenitor Organoid Cultures , 2019, Scientific Reports.

[6]  M. Exline,et al.  Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. , 2019, The Lancet. Respiratory medicine.

[7]  M. Matthay,et al.  Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS , 2018, Transfusion.

[8]  Patty J. Lee,et al.  Effects of bone marrow‐derived mesenchymal stromal cells on gene expression in human alveolar type II cells exposed to TNF‐α, IL‐1β, and IFN‐γ , 2018, Physiological reports.

[9]  J. Galipeau,et al.  Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. , 2018, Cell stem cell.

[10]  J. Laffey,et al.  Fifty Years of Research in ARDS., Cell‐based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value , 2017, American journal of respiratory and critical care medicine.

[11]  F. Guo,et al.  The Orphan Receptor Tyrosine Kinase ROR2 Facilitates MSCs to Repair Lung Injury in ARDS Animal Model , 2016, Cell transplantation.

[12]  P. Newsholme,et al.  Multi-lineage differentiation of mesenchymal stem cells - To Wnt, or not Wnt. , 2015, The international journal of biochemistry & cell biology.

[13]  H. Qiu,et al.  Interaction between mesenchymal stem cells and endothelial cells restores endothelial permeability via paracrine hepatocyte growth factor in vitro , 2015, Stem Cell Research & Therapy.

[14]  M. Matthay,et al.  Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. , 2014, The Lancet. Respiratory medicine.

[15]  Xinyan Wang,et al.  Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats , 2014, Molecular medicine reports.

[16]  F. Guo,et al.  Stable Genetic Alterations of β‐Catenin and ROR2 Regulate the Wnt Pathway, Affect the Fate of MSCs , 2014, Journal of cellular physiology.

[17]  F. Guo,et al.  Wnt5a through Noncanonical Wnt/JNK or Wnt/PKC Signaling Contributes to the Differentiation of Mesenchymal Stem Cells into Type II Alveolar Epithelial Cells In Vitro , 2014, PloS one.

[18]  A. Giordano,et al.  Silencing of RB1 and RB2/P130 during adipogenesis of bone marrow stromal cells results in dysregulated differentiation , 2014, Cell Cycle.

[19]  F. Guo,et al.  Activation of canonical wnt pathway promotes differentiation of mouse bone marrow‐derived MSCs into type II alveolar epithelial cells, confers resistance to oxidative stress, and promotes their migration to injured lung tissue in vitro , 2013, Journal of cellular physiology.

[20]  William F. Richter,et al.  Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation , 2012, Proceedings of the National Academy of Sciences.

[21]  O. Lee,et al.  miRNA-146a expression positively regulates tumor necrosis factor-α-induced interleukin-8 production in mesenchymal stem cells and differentiated lung epithelial-like cells. , 2012, Tissue engineering. Part A.

[22]  B. Popov,et al.  Induction of Wnt/β-catenin signaling in mouse mesenchymal stem cells is associated with activation of the p130 and E2f4 and formation of the p130/Gsk3β/β-catenin complex. , 2012, Stem cells and development.

[23]  Fang-bao Ding,et al.  Bone marrow mesenchymal stem cells can differentiate into type II alveolar epithelial cells in vitro , 2011, Cell biology international.

[24]  S. Archer,et al.  Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. , 2009, American journal of respiratory and critical care medicine.

[25]  V. Nurcombe,et al.  Wnt signaling controls the fate of mesenchymal stem cells. , 2009, Gene.

[26]  K. Fukunaga,et al.  Lithium-induced activation of Akt and CaM kinase II contributes to its neuroprotective action in a rat microsphere embolism model , 2006, Brain Research.

[27]  M. Beers,et al.  Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. , 2006, Microbes and infection.

[28]  M. Rojas,et al.  Bone marrow-derived mesenchymal stem cells in repair of the injured lung. , 2005, American journal of respiratory cell and molecular biology.

[29]  S. Boitano,et al.  EXTRACELLULAR MATRIX-DRIVEN ALVEOLAR EPITHELIAL CELL DIFFERENTIATION IN VITRO , 2005, Experimental lung research.

[30]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[31]  D. Heath,et al.  Expression Profiling and Functional Analysis of Wnt Signaling Mechanisms in Mesenchymal Stem Cells , 2004, Stem cells.

[32]  Naftali Kaminski,et al.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Kotton,et al.  Bone marrow-derived cells as progenitors of lung alveolar epithelium. , 2001, Development.

[34]  A. Fisher,et al.  Surfactant protein C: a review of its unique properties and metabolism. , 1992, The American journal of physiology.

[35]  Jie Shen,et al.  Overexpression of CXCR7 promotes mesenchymal stem cells to repair phosgene-induced acute lung injury in rats. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[36]  B. Thompson,et al.  Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. , 2015, The Lancet. Respiratory medicine.

[37]  M. Matthay,et al.  Alveolar epithelium: role in lung fluid balance and acute lung injury. , 2005, Proceedings of the American Thoracic Society.

[38]  Christof Niehrs,et al.  Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. , 2002, Nature.

[39]  S. Parlee,et al.  This Work Is Licensed under a Creative Commons Attribution-noncommercial 4.0 International License , 2022 .